In a murine liver tumor model, it was also shown that FAP+ CAFs are a major source of CCL2 and that fibroblastic STAT3-CCL2 signaling promotes tumor growth by enhancing the recruitment of MDSCs, which also predicts poor prognosis of patients with intrahepatic cholangiocarcinoma (149). The gene discussed is CCL2; the disease is neoplasm.